Abstract: A method for diagnosing rheumatoid arthritis, based on the detection of citrullinated autoantigens in a test sample is disclosed. The method diagnoses rheumatoid arthritis more accurately and rapidly. Also disclosed is a kit for carrying out the method.

Abstract: The present invention relates to a method for biologically producing heme-iron through microorganism cultivation, and to an iron supplementing composition containing the heme-iron produced by the same. The present invention provides a method for biologically producing heme-iron through microorganism cultivation, making it possible to economically produce heme-iron or heme-iron preparations which can be safely used as an iron supplement.

Abstract: The present invention relates to a transportation apparatus for patients, which is a transportation apparatus that transfers and moves a patient that is on a main body frame in which the legs thereof are mounted with moving wheels. The present invention includes: a sliding plate that is moved to slide to both sides along the widthwise direction, by a sliding and moving means, on the upper surface of the main body frame; a transport conveyor that is coupled to the upper portion of the sliding plate so as to be moved to slide with the sliding plate, and has a conveyor belt which rotate in the forward direction or reverse direction by a rotating and moving means, after the movement; and an operation unit that is disposed on the front surface of the main body frame in the lengthwise direction so as to operate the sliding plate and the transport conveyor by means of the sliding and moving means and the rotating and moving means.

Abstract: Provided is a method for preventing or treating hepatitis C by administrating a composition including, as an active ingredient, a Vitidis Vinferae Radix extract or a fraction thereof and, more specifically, to a Vitidis Vinferae Radix extract which is extracted with water and alcohol or a mixed solvent thereof, or a fraction thereof, which have remarkably low hepatotoxicity and exhibit an excellent effect of selectively inhibiting genome replication of a hepatitis C virus, and thus can be useful for preventing or treating hepatitis C.

Abstract: The present invention relates to a composition containing PIAS3 as an active ingredient for the prevention or treatment of cancer or immune disease. More specifically, the present invention relates to a composition containing the PIAS3 gene or an expressing protein thereof as an active ingredient for the prevention or treatment of cancer or immune disease, to an immunosuppressant composition, to a method for reducing or inhibiting undifferentiated T cells into Th17 cells using the PIAS3 gene or an expressing protein thereof, and to a method for activating regulatory T cells.

Abstract: A method for tracking a user's gaze point using a mobile terminal is provided. The method includes detecting the user's eye area from a camera that is mounted in the mobile terminal and selecting reference points of the eye area, detecting a pupil corresponding to an interest area that is obtained from the reference points, generating a first virtual grid of the eye area using a pickup image of a gaze point of the pupil corresponding to each corner of the display and generating a second virtual grid having the same division areas as those of the first virtual grid in the display, and mapping a position of the pupil within the second virtual grid area corresponding to a position of the pupil within the first virtual grid.

Abstract: A method for calculating the center of the anterior capsule includes the steps of: photographing the eyeball of a patient with an optical coherence tomography; generating a 3-dimensional image and coordinates based on the data obtained by the optical coherence tomography; photographing the eyeball of the patient to produce an eyeball image; and matching the 3-dimensional image and coordinates to the eyeball image so as to calculate the center of the anterior capsule of the patient.

Abstract: The use of SIRT7 (sirtuin 7) as a marker for diagnosis of liver cancer is described. The disclosure variously relates to a liver cancer diagnostic marker including SIRT7 gene, a liver cancer diagnostic composition, a kit and microarray including the same, and a method of diagnosing liver cancer using the same. Also described is a method for screening a substance capable of treating liver cancer by inhibiting the expression of SIRT7 gene or protein, and a composition for preventing or treating liver cancer, which includes such substance. The disclosure further relates to the use of SIRT7 gene as a cancer diagnostic marker and the anticancer use of inhibition of SIRT7 expression, as well as the use of the specific miRNA to regulate the cell cycle and inhibit tumor growth by the expression of SIRT7 gene.

Abstract: The present invention relates to an apparatus for creating a tactile sensation through non-invasive brain stimulation by using ultrasonic waves. The apparatus includes: an ultrasonic transducer module for inputting the ultrasonic waves to stimulate a specific part of the brain of a specified user non-invasively through at least one ultrasonic transducer unit; a compensating module for acquiring information on a range of tactile perception areas in the brain of the specified user and compensating properties of ultrasonic waves to be inputted to the specified user through the ultrasonic transducer unit by referring to the acquired information thereon; and an ultrasonic waves generating module for generating ultrasonic waves to be inputted to the specified user through the ultrasonic transducer unit by referring to a compensating value decided by the compensating module.

Abstract: The method for extracting salient object from stereoscopic video includes: dividing regions based on the similarity of color and the distance between pixels in a left-eye image and a right-eye image which are used for an input stereoscopic image; creating a disparity map based on a disparity obtained from a pixel difference of the left-eye image and the right-eye image; calculating a contrast-based saliency by comparing the divided regions and the divided regions of the disparity map; calculating a prior-knowledge-based saliency based on a prior-knowledge for the divided regions and the divided regions of the disparity map; and extracting salient regions of the image based on the contrast-based saliency and the prior-knowledge-based saliency.

Abstract: Provided is a use of an miRNA of an Epstein-Barr virus (EBV), more specifically, EBV miR-BART4-5p, miR-BART4-3p, miR-BART1-5p, miR-BART15-3p, miR-BART5-5p, miR-BART5-3p, miR-BART16-5p, miR-BART16-3p, miR-BART17-3p, miR-BART21-3p, miR-BART18-5p, miR-BART7-5p, miR-BART9-5p, miR-BART22-5p, miR-BART20-3p, miR-BART13-5p, miR-BART13-3p, miR-BART2-3p, and mimics thereof for promoting apoptosis or inhibiting cell growth.

Abstract: The present invention relates to a biodegradable suture-type cell delivery system, a preparation method thereof and a biodegradable suture comprising the same. The biodegradable suture-type cell delivery system has improved cell compatibility as a result of depositing a hydrophilic functional group-containing compound on the surface of a biodegradable suture yarn made of a biodegradable polymer, a portion of which has partially a bulky structure beneficial for the proliferation of cells or living tissue, so as to hydrophilically modify the surface, and then bonding a cell compatible material to the surface, and also functions as a cell culture scaffold, because the bulky structure is beneficial for the proliferation of cells. Accordingly, the biodegradable suture-type cell delivery system can improve the rate of engraftment of stem cells in vivo.

Abstract: Provided are a composition for stimulating differentiation of MSCs into osteoblasts, which includes cryptotanshinone, and an osteogenesis stimulator including cryptotanshinone and MSCs. When the cryptotanshinone is treated to the MSCs, the differentiation into osteoblasts is stimulated, and thus osteogenesis of a patient may be stimulated by directly transplanting the differentiation-induced MSCs to the patient. Accordingly, the composition or osteogenesis stimulator may be used to treat patients having disability requiring stimulation of osteogenesis such as osteoporosis, bone fracture, bone grafting including alveolar bone grafting for implant placement, or other bone defects.

Abstract: The invention relates to an MRI system, comprising: an examination table including a cradle in which a patient may be positioned; a magnetic assembly disposed in the examination table and including first and second electrode assemblies, the respective electrode surfaces of which are disposed so as to be perpendicularly spaced apart by a certain distance and opposite each other such that space for imaging may be formed therebetween; and an RF coil unit contactingly or contactlessly attached to a part of a patient to be examined or an attached part corresponding to the part to be examined, applying an RF pulse to the part of the patient to be examined, and detecting an MR signal from the examined part.

Abstract: The present invention provides an anticancer adjuvant containing pentoxifylline. Pentoxifylline inhibits a collagen synthesis in tumors and consequently increases the distribution of an anticancer drug or sensitivity of cancer cells, which thus provides an improved anticancer treatment effect.

Abstract: The present invention relates to a capsule endoscope for a photodynamic and sonodynamic therapy using magnetism. The capsule endoscope for a photodynamic and sonodynamic therapy using magnetism includes: an endoscope body; a light and ultrasonic wave irradiation part provided on an outer surface of the endoscope body, for irradiating light and ultrasonic waves having different wavelengths; and a photodynamic and sonodynamic therapy part connected to an outer surface of the endoscope body and including materials for a photodynamic and ultrasonic therapy, and the endoscope body has a positive electrode part and a negative electrode part having different polarities and is controlled such that the polarities are changed, and the photodynamic and sonodynamic therapy part is activated by photosensitizers leaked from a therapy part connected to the endoscope by light and ultrasonic waves irradiated by the light and ultrasonic wave irradiation part.

Abstract: The present invention relates to a composition comprising GRIM-19 protein as an active ingredient for preventing or treating obesity or lipid-related metabolic diseases. More particularly, the present invention relates to a composition for preventing or treating obesity or lipid-related metabolic diseases wherein the composition comprises GRIM-19 protein as an active ingredient for preventing or treating metabolic diseases caused by immune response disorders or interactions between genetic, metabolic, or environmental complex factors. The GRIM-19 protein according to the present invention exhibits excellent effectiveness not only in reducing lipocytes and total cholesterol content in the body, but also in suppressing the differentiation of cytotoxic Th17 cells that produce and secrete inflammatory cytokines. Also, GRIM-19 has been found to have excellent effectiveness in regulating a STAT3 mediated inflammatory response in an inflammatory environment related to obesity.

Abstract: The present invention relates to an apparatus for creating a tactile sensation through non-invasive brain stimulation by using ultrasonic waves. The apparatus includes: an ultrasonic transducer module for inputting the ultrasonic waves to stimulate a specific part of the brain of a specified user non-invasively through at least one ultrasonic transducer unit; a compensating module for acquiring information on a range of tactile perception areas in the brain of the specified user and compensating properties of ultrasonic waves to be inputted to the specified user through the ultrasonic transducer unit by referring to the acquired information thereon; and an ultrasonic waves generating module for generating ultrasonic waves to be inputted to the specified user through the ultrasonic transducer unit by referring to a compensating value decided by the compensating module.

Abstract: Provided are peptides having anti-angiogenic activity and a use thereof, and more particularly, to peptides for inhibiting angiogenesis, the peptides including amino acid sequence with potent anti-angiogenic activity, a composition for inhibiting angiogenesis, the composition including the peptides, a medicine for inhibiting angiogenesis, the medicine including the composition, and a method for inhibiting angiogenesis using the peptides. The peptides for inhibiting angiogenesis, the peptides including the amino acid sequence of the invention provides not only potent inhibitory activity on proliferation, migration and tube formation of vascular endothelial cells, but also potent in vivo anti-angiogenic activity and inhibitory activity on proliferation and migration of cancer cells. Therefore, the peptide for inhibiting angiogenesis can be efficaciously used as a treatment for various diseases including cancer with abnormal regulation of angiogenesis.

Abstract: A support member for correcting tooth irregularities is provided. The support member includes: a main body that extends in a longitudinal direction and includes a hook portion formed on an end portion thereof; and a plurality of leg portions each of which extends in a radial direction from a central portion of the main body and has a through-hole formed in an end portion thereof, wherein each of the plurality of leg portions is obliquely formed with respect to a line perpendicular to the longitudinal direction of the main body. The support member may be simply fixed to a palatine bone by fixing a fixing screw to the palatine bone without cutting a mucus membrane and may maintain a stable fixed state because the plurality of leg portions are fixed in an area other than a midpalatal suture area.